Attached files
| file | filename |
|---|---|
| EX-31.1 - CERTIFICATION - Citius Pharmaceuticals, Inc. | f10k2020ex31-1_citius.htm |
| EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Citius Pharmaceuticals, Inc. | f10k2020ex23-1_citius.htm |
| EX-32.1 - CERTIFICATION - Citius Pharmaceuticals, Inc. | f10k2020ex32-1_citius.htm |
| EX-10.24 - LICENSE AGREEMENT, DATED OCTOBER 6, 2020, BETWEEN NOVECITE, INC. AND NOVELLUS TH - Citius Pharmaceuticals, Inc. | f10k2020ex10-24_citius.htm |
| EX-31.2 - CERTIFICATION - Citius Pharmaceuticals, Inc. | f10k2020ex31-2_citius.htm |
| 10-K - ANNUAL REPORT - Citius Pharmaceuticals, Inc. | f10k2020_citiuspharma.htm |
Exhibit 21
Listing of Subsidiaries
| Name of Subsidiary | Jurisdiction of Incorporation | |
| Citius Pharmaceuticals, LLC | Massachusetts | |
| Leonard-Meron Biosciences, Inc. | Delaware | |
| NoveCite, Inc. | Delaware |